 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 1480 | 回復(fù): 7 | |||
| 當(dāng)前只顯示滿足指定條件的回帖，點(diǎn)擊這里查看本話題的所有回帖 | |||
luwangxing金蟲(chóng) (正式寫手)
|
[交流]
【轉(zhuǎn)帖】國(guó)產(chǎn)PVP遭遇FDA發(fā)難，過(guò)氧化物超標(biāo) 已有5人參與
|
||
|
原文：http://www.fda.gov/drugs/drugsafety/ucm230492.htm 博愛(ài)新開(kāi)源算是國(guó)內(nèi)PVP較為主要的供應(yīng)商吧 過(guò)氧化物超標(biāo)4倍 CP05，和CP10沒(méi)有檢查該項(xiàng)目 Advisory to Drug and Dietary Supplement Manufacturers, Compounding Pharmacies and Distributors of Excipients and Dietary Ingredients – FDA Detects High Levels of Peroxide in Crospovidone [10-21-2010] The U.S. Food and Drug Administration is alerting drug and dietary supplement manufacturers, compounding pharmacies, and distributors of Povidone analogs (Povidone/Copovidone/Crospovidone), that the agency recently detected excessive levels of peroxide in one lot of Crospovidone (cross linked polyvinyl N-pyrrolidone) manufactured by China-based Tianjin Boai NKY International Ltd1. The peroxide level found by the FDA in the lot was more than four (4) times the maximum level of peroxide (400 ppm) allowed by global compendial monographs. Other lots of Povidone analogs2 manufactured by this firm may also contain excessive levels of peroxide. An Import Alert has been issued to prevent further entry of Tianjin Boai NKY International Ltd Crospovidone into the U.S. market. To date, the FDA is not aware of any illnesses in the United States stemming from peroxide contamination. The level of peroxide found in this particular lot does not appear, on its own, to pose a significant health risk in drugs or dietary supplements. The FDA nonetheless remains concerned that elevated levels of peroxide can cause subpotent finished products. Crospovidone is a very common ingredient in drugs and dietary supplements. Peroxide is a potential impurity from the polymerization step involved in the manufacturing of Povidone analogs. Residual peroxide levels of <100 ppm have been reported to cause oxidative degradation.3 The FDA is concerned that drug manufacturers using excipients containing high levels of peroxides will observe a loss of drug potency and the formation of excessive impurities during the product shelf life. It is essential that users and distributors implement robust supplier management programs to assure that peroxide levels in Povidone analogs are in control for each batch received. Manufacturers using such excipients should employ sound risk management principles in establishing appropriate scrutiny (including peroxide testing regimen) and actions to take for a given supplier, including but not limited to the following: ( a ) review supplier history, including any relevant information on manufacturing reliability; ( b ) assess peroxide levels obtained from testing4 of past batches of Povidone analogs; ( c ) determine reliability of results reported on Certificates of Analysis; ( d ) consider information obtained from ongoing communications with suppliers; and ( e ) determine whether the quality of any finished product has been impacted. Manufacturers who use ingredients that might contain elevated levels of peroxide are advised to notify the FDA if they become aware of any further findings of quality problems or potentially related adverse events. 1 May also do business as Friends Union Enterprise (Jianjin) Ltd, Boai New Kaiyuan Pharmaceutical Company, Boai NKY Pharmaceuticals Ltd or Bluetech Chemicals Limited. 2 A recently published study also found elevated levels of peroxide in multiple lots of Povidone analogs, consistent with the FDA’s findings. (Silverstein, PhD, Irwin, Pharmaceutical Technology, Vol. 33, Issue 10, pp. 84-88, October 02, 2009. “The Case for Supplier Qualification.”) 3 Hartauer, et al, Pharm. Dev. Technol. 2000;5(3):303-10. “Influence of peroxide impurities in povidone and crospovidone on the stability of raloxifene hydrochloride in tablets: identification and control of an oxidative degradation product.” 4 A peroxide test is not currently listed in the USP monographs for crospovidone and povidone. However, a non-specific USP/EP method (see Copovidone NF) can be used to readily detect peroxide present at 400 ppm in Povidone analogs. Alternatively, a validated method shown to be specific for peroxide and having at least the same sensitivity as the compendial method may be used. For import alert information, please see: http://www.accessdata.fda.gov/cms_ia/importalert_189.html 這是我在sfda網(wǎng)站看到的。據(jù)我所知，巴斯夫的交聯(lián)吡咯烷酮的COA中有這一項(xiàng)指標(biāo)，標(biāo)準(zhǔn)是不大于400ppm。 |
回復(fù)此樓» 猜你喜歡
332求調(diào)劑
已經(jīng)有7人回復(fù)
-
348求調(diào)劑
已經(jīng)有4人回復(fù)
-
305求調(diào)劑
已經(jīng)有8人回復(fù)
-
一志愿北京化工大學(xué)材料與化工（085600）296求調(diào)劑
已經(jīng)有13人回復(fù)
-
調(diào)劑310
已經(jīng)有9人回復(fù)
-
本科雙非材料，跨考一志愿華電085801電氣，283求調(diào)劑，任何專業(yè)都可以
已經(jīng)有8人回復(fù)
-
調(diào)劑求院校招收
已經(jīng)有6人回復(fù)
-
085600 材料與化工 329分求調(diào)劑
已經(jīng)有11人回復(fù)
-
求收留
已經(jīng)有3人回復(fù)
-
0856求調(diào)劑
已經(jīng)有14人回復(fù)
» 本主題相關(guān)價(jià)值貼推薦，對(duì)您同樣有幫助:
- 轉(zhuǎn)：具有全新降低血糖機(jī)制的新藥被fda專家小組否定
已經(jīng)有3人回復(fù)
reallove2935
禁言 (著名寫手)
★
小木蟲(chóng)(金幣+0.5):給個(gè)紅包，謝謝回帖交流
小木蟲(chóng)(金幣+0.5):給個(gè)紅包，謝謝回帖交流
|
本帖內(nèi)容被屏蔽 |
3樓2010-10-26 14:03:00
tjegg
鐵桿木蟲(chóng) (著名寫手)
- 應(yīng)助: 26 (小學(xué)生)
- 金幣: 6869.3
- 紅花: 16
- 帖子: 2615
- 在線: 448小時(shí)
- 蟲(chóng)號(hào): 338983
- 注冊(cè): 2007-04-05
- 性別: GG
- 專業(yè): 抗腫瘤藥物藥理
2樓2010-10-26 10:31:59
tjegg
鐵桿木蟲(chóng) (著名寫手)
- 應(yīng)助: 26 (小學(xué)生)
- 金幣: 6869.3
- 紅花: 16
- 帖子: 2615
- 在線: 448小時(shí)
- 蟲(chóng)號(hào): 338983
- 注冊(cè): 2007-04-05
- 性別: GG
- 專業(yè): 抗腫瘤藥物藥理
4樓2010-10-26 15:04:13
meteord
木蟲(chóng) (正式寫手)
- 應(yīng)助: 17 (小學(xué)生)
- 金幣: 5330.2
- 散金: 68
- 紅花: 1
- 帖子: 436
- 在線: 192.9小時(shí)
- 蟲(chóng)號(hào): 862641
- 注冊(cè): 2009-10-04
- 性別: GG
- 專業(yè): 藥劑學(xué)
7樓2010-10-28 09:15:57
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 299求調(diào)劑 +8 | 15188958825 2026-03-25 | 8/400 |
|
|---|---|---|---|---|
|
[考研] 一志愿太原理工安全工程300分，求調(diào)劑 +5 | 0857求調(diào)劑. 2026-03-24 | 6/300 |
|
|
|
[考研] 11408軟件工程求調(diào)劑 +3 | Qiu學(xué)ing 2026-03-28 | 3/150 |
|
|
|
[考研] 材料與化工（0856）304求B區(qū)調(diào)劑 +8 | 邱gl 2026-03-27 | 8/400 |
|
|
|
[考研] 調(diào)劑 +3 | 好好讀書。 2026-03-28 | 3/150 |
|
|
|
[考研] 292求調(diào)劑 +14 | 鵝鵝鵝額額額額?/a> 2026-03-25 | 15/750 |
|
|
|
[考研] 311求調(diào)劑 +3 | 希望上岸阿小楊 2026-03-23 | 3/150 |
|
|
|
[考研] 070300化學(xué)求調(diào)劑 +4 | 起個(gè)名咋這么難 2026-03-27 | 4/200 |
|
|
|
[考研] 312求調(diào)劑 +9 | 上岸吧ZJY 2026-03-22 | 13/650 |
|
|
|
[考研] 0703化學(xué)求調(diào)劑 +3 | 丹青奶蓋 2026-03-26 | 5/250 |
|
|
|
[考研] 求調(diào)劑 +8 | Auroracx 2026-03-22 | 8/400 |
|
|
|
[考研] 281求調(diào)劑 +3 | 亞克西good 2026-03-26 | 5/250 |
|
|
|
[考研] 機(jī)械學(xué)碩310分，數(shù)一英一，一志愿211本科雙非找調(diào)劑信息 +3 | @357 2026-03-25 | 3/150 |
|
|
|
[考研] 打過(guò)很多競(jìng)賽，085406控制工程300分，求調(diào)劑 +3 | askeladz 2026-03-26 | 3/150 |
|
|
|
[考研] 26考研-291分-廈門大學(xué)（085601）-柔性電子學(xué)院材料工程專業(yè)求調(diào)劑 +3 | min3 2026-03-24 | 4/200 |
|
|
|
[考研] 0854AI CV方向招收調(diào)劑 +4 | 章小魚567 2026-03-23 | 4/200 |
|
|
|
[考研] 0854電子信息求調(diào)劑 +7 | α____ 2026-03-22 | 9/450 |
|
|
|
[考研] 340求調(diào)劑 +5 | 話梅糖111 2026-03-24 | 5/250 |
|
|
|
[考研] 生物學(xué)學(xué)碩求調(diào)劑 +7 | 小羊睡著了? 2026-03-23 | 10/500 |
|
|
|
[有機(jī)交流]
 有機(jī)合成求助
 20+3
|
FENGSHUJEI 2026-03-23 | 5/250 |
|